Your browser doesn't support javascript.
loading
The effect of cigarette smoking on the clinical and serological phenotypes of polymyositis and dermatomyositis.
Schiffenbauer, Adam; Faghihi-Kashani, Sara; O'Hanlon, Terrence P; Flegel, Willy A; Adams, Sharon D; Targoff, Ira N; Oddis, Chester V; Ytterberg, Steven R; Aggarwal, Rohit; Christopher-Stine, Lisa; Shamim, Ejaz A; Dellaripa, Paul F; Danoff, Sonye K; Mammen, Andrew L; Miller, Frederick W.
Afiliación
  • Schiffenbauer A; Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD. Electronic address: schiffenbauera2@niehs.nih.gov.
  • Faghihi-Kashani S; Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD.
  • O'Hanlon TP; Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD.
  • Flegel WA; Department of Transfusion Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, MD.
  • Adams SD; Department of Transfusion Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, MD.
  • Targoff IN; Veterans Affairs Medical Center, University of Oklahoma Health Sciences Center, Oklahoma Medical Research Foundation, Oklahoma City, OK.
  • Oddis CV; Myositis Center, University of Pittsburgh School of Medicine, Pittsburgh, PA.
  • Ytterberg SR; Division of Rheumatology, Mayo Clinic, Rochester, MN.
  • Aggarwal R; Myositis Center, University of Pittsburgh School of Medicine, Pittsburgh, PA.
  • Christopher-Stine L; Johns Hopkins Myositis Center, Johns Hopkins University School of Medicine, Baltimore, MD; Departments of Neurology and Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Shamim EA; Department of Neurology, Mid-Atlantic Permanente Research Institute, Kaiser Permanente, Rockville, MD.
  • Dellaripa PF; Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA.
  • Danoff SK; Division of Pulmonary and Critical Care Medicine, Johns Hopkins School of Medicine, Baltimore, MD.
  • Mammen AL; Departments of Neurology and Medicine, Johns Hopkins University School of Medicine, Baltimore, MD; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD.
  • Miller FW; Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD.
Semin Arthritis Rheum ; 48(3): 504-512, 2018 12.
Article en En | MEDLINE | ID: mdl-29703532
OBJECTIVE: Cigarette smoking is associated with immune-mediated disorders. We explored the contribution of smoking to polymyositis (PM) and dermatomyositis (DM) phenotypes and attempted to determine whether cigarette smoking effects differ by race and genotype. METHODS: Associations of tobacco smoking with disease features, autoantibodies, HLA types, and race were evaluated using multiple logistic regressions in 465 patients. RESULTS: Caucasian ever-smokers (n = 140) were more likely to have PM (adjusted OR = 2.24, 95% CI: 1.41\x963.57), anti-synthetase (adjusted OR = 1.93, 95% CI: 1.12\x963.34) and anti-Jo-1 autoantibodies (adjusted OR = 1.94, 95% CI: 1.08\x963.46) and less likely to have anti-p155/140 autoantibodies (adjusted OR = 0.36, 95% CI: 0.14\x960.92). In Caucasians, ever-smokers had a greater interstitial lung disease (ILD) frequency than never-smokers, while in African-Americans this relationship was inverted, but neither trend reached statistical significance. Pack-years of cigarette smoking showed significant positive associations with PM (adjusted OR = 1.02, 95% CI: 1.002\x961.04) and ILD (adjusted OR = 1.02, 95% CI: 1.001\x961.03) and was inversely associated with anti-p155/140 autoantibodies (adjusted OR = 0.93, 95% CI: 0.87\x960.99) in Caucasians. Caucasian heavy smokers (=20 pack-years) were more likely to have PM (adjusted OR = 2.52, 95% CI: 1.25\x965.09), ILD (adjusted OR = 2.48, 95% CI: 1.23\x965.00) and anti-Jo-1 autoantibodies (adjusted OR = 2.65, 95% CI: 1.16\x966.08) than never-smokers. In Caucasians, compared to never-smokers without HLA-DRB1*03:01 allele, ever-smokers with HLA-DRB1*03:01 allele had the highest odds of PM, ILD, ASA, and anti-Jo-1 autoantibodies. Risks for those with only one of these two factors were intermediate. An inverse pattern was observed regarding anti-p155/140 autoantibodies. CONCLUSION: Tobacco smoking was associated with clinical and autoantibody phenotypes in Caucasians. Our findings also suggest possible interactions among HLA-DRB1*03:01 and smoking on the risk of PM and ILD, as well as, anti-synthetase, anti-Jo-1, and anti-p155/140 autoantibodies in Caucasians.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Autoanticuerpos / Polimiositis / Dermatomiositis / Fumar Cigarrillos Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Semin Arthritis Rheum Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Autoanticuerpos / Polimiositis / Dermatomiositis / Fumar Cigarrillos Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Semin Arthritis Rheum Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos